615 related articles for article (PubMed ID: 30065557)
1. Considerations for bariatric surgery in patients with cirrhosis.
Goh GB; Schauer PR; McCullough AJ
World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
[TBL] [Abstract][Full Text] [Related]
2. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
4. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM
Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616
[TBL] [Abstract][Full Text] [Related]
7. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.
Jan A; Narwaria M; Mahawar KK
Obes Surg; 2015 Aug; 25(8):1518-26. PubMed ID: 25982807
[TBL] [Abstract][Full Text] [Related]
9. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
Giannini EG; Coppo C; Romana C; Camerini GB; De Cian F; Scopinaro N; Papadia FS
Dig Dis Sci; 2018 Jul; 63(7):1946-1951. PubMed ID: 29629490
[TBL] [Abstract][Full Text] [Related]
12. Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.
Bai J; Jia Z; Chen Y; Li Y; Zheng S; Duan Z
World J Surg; 2022 May; 46(5):1122-1133. PubMed ID: 35275232
[TBL] [Abstract][Full Text] [Related]
13. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
[TBL] [Abstract][Full Text] [Related]
14. Bariatric Surgery in Cirrhotic Patients: Is It Safe?
Younus H; Sharma A; Miquel R; Quaglia A; Kanchustambam SR; Carswell KA; Patel AG
Obes Surg; 2020 Apr; 30(4):1241-1248. PubMed ID: 31853866
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
[TBL] [Abstract][Full Text] [Related]
17. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
18. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery and non-alcoholic fatty liver disease.
Julià H; Benaiges D; Pedro-Botet J
Med Clin (Barc); 2022 Jun; 158(11):550-555. PubMed ID: 35120767
[TBL] [Abstract][Full Text] [Related]
20. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.
Bower G; Toma T; Harling L; Jiao LR; Efthimiou E; Darzi A; Athanasiou T; Ashrafian H
Obes Surg; 2015 Dec; 25(12):2280-9. PubMed ID: 25917981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
